Congenital Hyperinsulinism International is a US-based 501(c)3 nonprofit organization dedicated to improving the lives of individuals affected by congenital hyperinsulinism, a rare disorder that can cause severe hypoglycemia if not managed properly. With an operating budget of $1 million and total revenue of $1.3 million, CHI relies on significant support from major funders, including FIDELITY INVESTMENTS CHARITABLE GIFT FUND and Silicon Valley Community Foundation, among others, ensuring a diverse funding base without dependence on a single source for over 50% of its revenue. More information can be found at www.congenitalhi.org.